Search Results

There are 3935 results for: content related to: Drug-resistance development differs between HIV -1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

  1. You have full text access to this OnlineOpen article
    Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

    HIV Medicine

    A Bamford, A Turkova, H Lyall, C Foster, N Klein, D Bastiaans, D Burger, S Bernadi, K Butler, E Chiappini, P Clayden, M Della Negra, V Giacomet, C Giaquinto, D Gibb, L Galli, M Hainaut, M Koros, L Marques, E Nastouli, T Niehues, A Noguera-Julian, P Rojo, C Rudin, HJ Scherpbier, G Tudor-Williams, SB Welch and (PENTA Steering Committee)

    Version of Record online : 3 FEB 2015, DOI: 10.1111/hiv.12217

  2. You have free access to this content
    British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015

    HIV Medicine

    Volume 17, Issue S4, August 2016, Pages: s2–s104, Duncan Churchill, Laura Waters, Nadia Ahmed, Brian Angus, Marta Boffito, Mark Bower, David Dunn, Simon Edwards, Carol Emerson, Sarah Fidler, Martin Fisher, Rob Horne, Saye Khoo, Clifford Leen, Nicola Mackie, Neal Marshall, Fernando Monteiro, Mark Nelson, Chloe Orkin, Adrian Palfreeman, Sarah Pett, Andrew Phillips, Frank Post, Anton Pozniak, Iain Reeves, Caroline Sabin, Roy Trevelion, John Walsh, Ed Wilkins, Ian Williams and Alan Winston

    Version of Record online : 29 AUG 2016, DOI: 10.1111/hiv.12426

  3. You have free access to this content
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)

    HIV Medicine

    Volume 15, Issue S4, September 2014, Pages: 1–77,

    Version of Record online : 25 SEP 2014, DOI: 10.1111/hiv.12185

  4. You have free access to this content
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012

    HIV Medicine

    Volume 13, Issue S2, August 2012, Pages: 87–157, Dr GP Taylor, Ms P Clayden, Dr J Dhar, Mrs K Gandhi, Dr Y Gilleece, Dr K Harding, Dr P Hay, Ms J Kennedy, Dr N Low-Beer, Dr H Lyall, Dr A Palfreeman, Dr P Tookey, Dr S Welch, Dr E Wilkins and Dr A de Ruiter

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1468-1293.2012.01030.x

  5. You have free access to this content
    Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study

    HIV Medicine

    Volume 14, Issue 6, July 2013, Pages: 327–336, E Ribera, M Larrousse, A Curran, E Negredo, B Clotet, V Estrada, J Sanz, J Berenguer, R Rubio, F Pulido, P Ferrer, ML Alvarez, S Arterburn and E Martínez

    Version of Record online : 9 JAN 2013, DOI: 10.1111/hiv.12011

  6. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

    HIV Medicine

    Volume 16, Issue 2, February 2015, Pages: 122–131, HG Sprenger, N Langebeek, PGH Mulder, CHH ten Napel, R Vriesendorp, AIM Hoepelman, JC Legrand, PP Koopmans, B Bravenboer, RW ten Kate, PHP Groeneveld, WFW Bierman, TS van der Werf, EH Gisolf and C Richter

    Version of Record online : 4 DEC 2014, DOI: 10.1111/hiv.12186

  7. You have free access to this content
    British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015

    HIV Medicine

    Volume 17, Issue S3, August 2016, Pages: s2–s81, Prof Anna Maria Geretti, Dr Gary Brook, Ms Claire Cameron, Dr David Chadwick, Prof Neil French, Prof Robert Heyderman, Dr Antonia Ho, Dr Michael Hunter, Dr Shamez Ladhani, Dr Mark Lawton, Dr Eithne MacMahon, Dr John McSorley, Dr Anton Pozniak and Dr Alison Rodger

    Version of Record online : 29 AUG 2016, DOI: 10.1111/hiv.12424

  8. Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

    HIV Medicine

    Volume 15, Issue 9, October 2014, Pages: 513–524, G Tudor-Williams, P Cahn, K Chokephaibulkit, J Fourie, C Karatzios, S Dincq, M Opsomer, TN Kakuda, S Nijs, L Tambuyzer, FL Tomaka and on behalf of the PIANO study group

    Version of Record online : 3 MAR 2014, DOI: 10.1111/hiv.12141

  9. You have free access to this content
    Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 488–498, KN Simpson, S-Y Chen, AW Wu, L Boulanger, R Chambers, K Nedrow, M Tawadrous, CL Pashos and S Haider

    Version of Record online : 18 MAR 2014, DOI: 10.1111/hiv.12145

  10. You have free access to this content
    Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    HIV Medicine

    Volume 16, Issue S1, April 2015, Pages: 77–87, JD Baxter, D Dunn, E White, S Sharma, AM Geretti, MJ Kozal, MA Johnson, S Jacoby, JM Llibre, J Lundgren and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

    Version of Record online : 25 FEB 2015, DOI: 10.1111/hiv.12236

  11. You have free access to this content
    Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions

    HIV Medicine

    Volume 15, Issue 4, April 2014, Pages: 224–232, W Tinago, JA O'Halloran, RM O'Halloran, A Macken, JS Lambert, GJ Sheehan and PWG Mallon

    Version of Record online : 12 NOV 2013, DOI: 10.1111/hiv.12107

  12. You have free access to this content
    Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials

    HIV Medicine

    Volume 14, Issue 5, May 2013, Pages: 284–292, C Stephan, A Hill, W Sawyer, Y van Delft and C Moecklinghoff

    Version of Record online : 22 NOV 2012, DOI: 10.1111/hiv.12004

  13. You have free access to this content
    A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction

    HIV Medicine

    Volume 15, Issue 5, May 2014, Pages: 301–310, J Baril, B Conway, P Giguère, N Ferko, S Hollmann and JB Angel

    Version of Record online : 9 DEC 2013, DOI: 10.1111/hiv.12118

  14. Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens

    HIV Medicine

    D Armenia, D Di Carlo, G Maffongelli, V Borghi, C Alteri, F Forbici, A Bertoli, C Gori, M Giuliani, E Nicastri, M Zaccarelli, C Pinnetti, S Cicalini, G D'Offizi, F Ceccherini-Silberstein, C Mussini, A Antinori, M Andreoni, CF Perno and MM Santoro

    Version of Record online : 28 JUN 2016, DOI: 10.1111/hiv.12388

  15. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  16. You have free access to this content
    Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial

    HIV Medicine

    Volume 15, Issue 7, August 2014, Pages: 431–441, JE Lake, GA McComsey, T Hulgan, CA Wanke, A Mangili, SL Walmsley, SA Stramotas, R Tracy and JS Currier

    Version of Record online : 10 FEB 2014, DOI: 10.1111/hiv.12128

  17. You have free access to this content
    8.0 Antiretroviral therapy in specific populations

    HIV Medicine

    Volume 15, Issue S1, January 2014, Pages: 58–81,

    Version of Record online : 16 DEC 2013, DOI: 10.1111/hiv.12119_9

  18. You have free access to this content
    Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start

    HIV Medicine

    Volume 15, Issue 3, March 2014, Pages: 165–174, C Angeletti, P Pezzotti, A Antinori, A Mammone, A Navarra, N Orchi, P Lorenzini, A Mecozzi, A Ammassari, S Murachelli, G Ippolito and E Girardi

    Version of Record online : 31 OCT 2013, DOI: 10.1111/hiv.12097

  19. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review

    HIV Medicine

    Volume 17, Issue 6, June 2016, Pages: 411–424, CT Lambert, PB Sandesara, B Hirsh, LJ Shaw, W Lewis, AA Quyyumi, RF Schinazi, WS Post and L Sperling

    Version of Record online : 26 NOV 2015, DOI: 10.1111/hiv.12346

  20. You have free access to this content
    Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 478–487, M Meresse, L March, C Kouanfack, R-C Bonono, S Boyer, G Laborde-Balen, A Aghokeng, M Suzan-Monti, E Delaporte, B Spire, M-P Carrieri, C Laurent and Stratall ANRS 12110/ESTHER Study Group

    Version of Record online : 3 MAR 2014, DOI: 10.1111/hiv.12140